Introduction
Aflatoxin B 1 (AFB 1 ) (Figure 1 ) is produced by several fungal species that contaminate food supplies (reviewed in ref. 1 ). Exposure to AFB 1 is especially high in underdeveloped countries with a warm, moist climate (2) . Developed countries have set strict standards for the aflatoxin levels in food, but AFB 1 contamination is nevertheless responsible for substantial economic losses to corn crops in the southern and mid-western USA (3) . AFB 1 is cytotoxic and mutagenic in bacteria, and toxic and carcinogenic in animals (1, 4) . Epidemiological studies link AFB 1 exposure to hepatocellular carcinoma incidence, especially in the situations in which AFB 1 exposure is accompanied with hepatitis B virus infection (5EE9). Interestingly, in more than half of these latter cases, a characteristic G to T mutation at the third position of codon 249 of the p53 gene is present (10) . In addition, some epidemiological data suggest a link between inhalation of AFB 1 contaminated grain dusts and increased lung cancer risks in certain occupational settings (11) . AFB 1 is activated by cytochrome P450 enzymes (12) forming the AFB 1 -8,9-epoxide ( Figure 1 ), which is capable of covalent modification of DNA, preferentially at the N 7 position of guanine (dG). The resulting cationic adduct is labile and can depurinate or, alternatively, undergo a base-catalyzed reaction during which the imidazole ring of dG opens and a stable 8,9-dihydro-8(2,6-diamino-4-oxo-3,4-dihydropyrimid-5-yl-formamido)-9-hydroxyaflatoxin B 1 (AFB 1 -FAPY) adduct is formed (4, 13) . It is possible that all three lesions contribute to the observed biological effects of AFB 1 exposure. Using sitespecific, lesion-directed mutagenesis experiments, it has been shown that both cationic AFB 1 -N 7 -dG, 8,9-dihydro-8-(N 7 -guanyl)-9-hydroxyaflatoxin B 1 (AFB 1 -N 7 -dG) and AFB 1 -FAPY adducts cause the same types of mutations (mostly G to T transversions) at the site of the lesion and some mutations 5
H to the lesion (14, 15) . In these studies, the AFB 1 -FAPY adduct was found to be six times more mutagenic and caused a much stronger blocking effect on DNA replication than the AFB 1 -N 7 -dG adduct (14) . Nuclear magnetic resonance (NMR) studies have been performed on the structures of the aflatoxin adducts in doublehelical DNA (16EE21). Both AFB 1 -N 7 -dG and AFB 1 -FAPY adducts form similar structures in which the AFB 1 moiety is intercalated on the 5 H side of the modified base, which remains in H-bonding alignment with the complementary cytosine. The differences between the structures of DNA containing each of the two studied aflatoxin adducts are minor, despite the fact that a significantly different extent of DNA duplex stabilization by those adducts is observed (the difference is up to 12 C in terms of melting temperatures) (22) . One goal of the present work was to elucidate if the differences between AFB 1 -N 7 -dG and AFB 1 -FAPY adduct structures are significant enough for repair enzymes to recognize and repair these lesions differentially, especially as it has been shown that in mammalian cells (but not in bacteria) AFB 1 -FAPY adducts persist for many days to weeks, while the AFB 1 -N 7 -dG adducts are efficiently removed (23EE25). Nucleotide excision repair (NER) plays an important role in removing many bulky adducts in organisms from bacteria to humans (26) , and its importance upon AFB 1 exposure has been established (27EE31). Also, it has been demonstrated that E.coli uvrABC enzymes bind and incise both AFB 1 -N 7 -dG and AFB 1 -FAPY with equal efficiency in vitro (32) . In contrast, it has been shown that the formamidopyrimidine DNA glycosylase (Fpg) protein (MutM), a base excision repair (BER) glycosylase that removes a variety of oxidation-derived lesions including purine imidazole ring-opened species (33) , is also capable of removing AFB 1 -FAPY, but not AFB 1 -N 7 -dG, in vitro (34). It has not been established if NER or BER is the preferred biologically relevant pathway for removal of AFB 1 -FAPY lesions in vivo.
In order to determine the preferred pathway of AFB 1 adduct removal in vivo, we used a modified host cell reactivation (HCR) assay (35, 36) in which E.coli cells with different repair backgrounds were transformed with plasmids bearing a reporter gene. Prior to transformation of cells, the plasmids were enriched for either AFB 1 -N 7 -dG or AFB 1 -FAPY lesions. The results of these experiments suggest that AFB 1 -FAPY lesions are repaired in vivo by NER, whereas the role of the Fpg protein in this case is negligible. In addition, our in vitro comparison of the cleavage efficiencies of the damaged DNA by the Fpg protein and its human ortholog 8-oxoguanine DNA glycosylase (hOGG1) suggests that the AFB 1 -FAPY lesion is a surprisingly poor substrate for these enzymes, compared with the canonical substrates 7,8-dihydro-8-oxoguanine (8-oxoG) and methyl-formamidopyrimidine (Me-FAPY) (37) .
Materials and methods

Materials
Fpg and hOGG1 proteins were gifts from Gregory L.Verdine (Harvard University). Fpg protein was also purchased from Trevigen (Gaithersburg, MD). The Klenow fragment (KF) of E.coli DNA polymerase I was from Amersham Pharmacia Biotech (Piscataway, NJ). The protein had been overproduced and purified from a strain carrying a double mutation D355A, E357A, which results in~10 5 -fold reduction of endogenous 3 H EE5 H exonuclease activity (38) .
Plasmids pSP72 (2462 bp) bearing the ampicillin resistance gene were purchased from Promega (Madison, WI). To amplify the plasmids, competent DH5a cells were transformed with the pSP72 plasmids and re-grown from a single colony in ampicillin-containing media as described in (39) ; the plasmids were purified using a Qiagen (Valencia, CA) plasmid kit according to the manufacturer's protocol.
Oligonucleotides were obtained from Qiagen. dNTPs were purchased from Promega. [g-32 P]ATP was from ICN Biomedicals (Irvine, CA). AFB 1 was purchased from Sigma. AFB 1 labeled with tritium was from Moravek Biochemicals (Brea, CA). All other general reagents and chemicals were obtained from Fisher (Pittsburgh, PA), Aldrich (Milwaukee, WI) and VWR (West Chester, PA).
Synthesis and purification of the AFB 1 -modified DNA An oligonucleotide (a 13mer, 5 H -CCTCTTCGAACTC-3 H ) containing a single dG was purified by 20% denaturing polyacrylamide gel electrophoresis (PAGE) in the presence of 8 M urea according to the procedures described in (40) . The oligonucleotides were detected under UV light; the relevant area was cut out, eluted overnight and desalted by spin-dialysis using centricon-3 microconcentrators (Amicon, Bedford, MA) according to the manufacturer's protocol. The oligonucleotide was allowed to react with AFB 1 -8,9-epoxide (obtained as described in ref. 41 ) to produce either AFB 1 -N 7 -dG or AFB 1 -FAPY adducts as described in detail (14, 32, 42) . Briefly, the DNA (~90 nmol) was resuspended in 100 ml of 10 mM phosphate buffer (Na 2 HPO 4 ) containing 100 mM NaCl, 50 mM EDTA (pH 7) and 50 ml of acetone solution containing 5.6 mmol of AFB 1 -epoxide was added. The mixture was shaken at 4 C for 15 min, after which another 50 ml of the same AFB 1 -epoxide solution was added and incubated for another 15 min. The unreacted AFB 1 products were C [or in 0.1 M Na 2 HPO 4 (pH 9.0) at 37 C for 4 h] to convert AFB 1 -N 7 -dG into AFB 1 -FAPY, and purified by HPLC as before (see above). The identities of the lesions were confirmed by MALDI-TOF MS using unmodified 13mer and 15mer oligonucleotides as internal calibration standards (data not shown) as described (14) . Modified 13mer subjected to acid hydrolysis (0.1 M HCl for 30 min at 80 C) was used as a standard in HPLC analysis (same conditions as above) of the modified plasmids ( Figure 2A ).
The pSP72 plasmid was modified under the same conditions as the 13mer oligonucleotide, but using a range of AFB 1 -epoxide concentrations to produce plasmids bearing a different number of adducts. Plasmid DNA (37 mg) in 50 ml of 10 mM phosphate buffer containing 100 mM NaCl, 50 mM EDTA (pH 7) was incubated with 50 ml of acetone solution containing from 20 nmol to 5.6 mmol of AFB 1 -epoxide. A 400:1 molar ratio of cold to tritiated AFB 1 -epoxide was used to allow the quantification of the adducts; after purification, the number of adducts per plasmid was determined as a ratio of the concentration of AFB 1 determined by scintillation counting to the DNA concentration determined by UV spectroscopy. A portion of the modified plasmid was incubated in 0.1 M NaOH for 10 min in 37 C to convert AFB 1 -N 7 -dG into AFB 1 -FAPY. The unreacted AFB 1 products were extracted twice with 100 ml of CH 2 Cl 2 and the modified plasmids (aqueous solution) was further purified using G-25 Sephadex columns (Roche). To confirm the identities of the lesions, the plasmids modified with the highest amount of AFB 1 -epoxide were subjected to HCl hydrolysis (0.1 M HCl for 30 min at 80 C) and the products were analyzed by reversed phase HPLC analysis using the same conditions as described above and compared with the standards from modified 13mer oligonucleotide ( Figure 2 ). Plasmids used as unmodified controls were mock-treated exactly mimicking the modification procedure for the AFB 1 -N 7 -dG or AFB 1 -FAPY adducts, except that the AFB 1 -epoxide was omitted. The extent of the supercoiling of the treated and mock-treated plasmids was the same as determined from agarose gel analysis (data not shown). . The cells were prepared for transformation as described (15) . For each transformation, 100 ml of the cell suspension was added to 0.1 mg of the plasmid DNA (pSP72 unmodified, or containing from 0 to 50 adducts per plasmid of either AFB 1 -N 7 -dG or AFB 1 -FAPY). The mixture was transferred to a cold Bio-Rad (Hercules, CA) gene pulser cuvette (0.2 cm) and electroporations were performed with a BTX Electro Cell Manipulator 600 set at 2.5 kV and 129 V. Immediately after electroporation, 900 ml of M9 media was added and after 3 h of recovery at 37 C, the cells were plated on LB plates containing ampicillin. The percentage of survival was determined as a ratio of the normalized number of colonies that formed from the cells transformed with modified plasmid to that of cells transformed with the mock-treated plasmid. The survival of the cells transformed with the mock-treated plasmid (0 adducts/plasmid) was set as 100%. To account for plating efficiency, the number of colonies on the ampicillin-containing plates was normalized by dividing by the number of colonies that grew on plates without ampicillin. The percentage of survival was plotted as a function of the number of adducts per plasmid.
Host cell reactivation assay
Interactions of MutM and hOGG1 proteins with DNA containing 7,8-dihydro-8-oxoguanine, methyl-formamidopyrimidine or AFB 1 -FAPY lesions in vitro A 20mer oligonucleotide (5 H -CCAACTTCCXCATCTACACC-3 H ) containing 8-oxoG was synthesized using the phosphoramidite method, purified using reverse-phase HPLC as described in (43) and desalted with Centricon-3 microconcentrators (Amicon) according to the manufacturer's protocol. The Me-FAPY lesions were generated by primer extension with KF using procedures similar to those described in (37) . A 32 P-labeled 9mer primer oligonucleotide 5 H -32 P-CCAACTTCC-3 H (100 pmol) and an equimolar 25mer complementary template (5 H -GGTGTAGATGCGGAAGTTG-GAAAGG-3 H ) with a 5-nt overhang was annealed by heating and slow cooling in 50 mM TrisEEHCl, pH 7.5, 10 mM MgCl 2 , 1 mM dithiothreitol and 0.05 mg/ml bovine serum albumin. To the annealed primer-template duplex was added 7-methyl-2
, dCTP (20 mM) and 20 U of Klenow Fragment (final volume 30 ml). After 45 min at 37 C, the fulllength replication product (20mer) was purified by 20% PAGE in the presence of 8 M urea as described in (40) . The m 7 -dG was converted into its ring-opened Me-FAPY form by incubating the modified 20mer in the presence of 50 mM phosphate buffer (pH 11) for 5 h at 37 C. The 20mer containing AFB 1 -FAPY was obtained and purified under the conditions described above for the 13mer oligonucleotide.
The substrates (10 pmol) were 5 H -end-labeled with T4 polynucleotide kinase and [g-32 P]ATP (except for the 20mer with Me-FAPY, which was labeled during preparation) and annealed to complementary unmodified 20mers by heating and slow cooling in either 10 mM HEPESEEKOH (pH 7.4) buffer containing 100 mM KCl and 10 mM EDTA, or in 20 mM TrisEECl buffer (pH 8.0), containing 1 mM DTT, 1 mM EDTA and 0.1 mg/ml BSA, which are the reaction buffers for Fpg and hOGG1, respectively. Fpg (150 nM or 0.5 U/ml for Trevigen enzyme) or hOGG1 enzymes (2.5 mM) were added to 10 ml reactions and were incubated for 45 min at 37 C. The reactions were stopped with formamide and the products were analyzed using 20% PAGE (0.4 mm) in the presence of 8 M urea.
To produce a stable covalent cross-link between Fpg and substrate duplex DNA, aliquots of reaction mixtures were incubated for 45 min at 37 C in the presence of NaBH 4 (50 mM). Reactions were quenched by addition of equal volumes of loading buffer containing sodium dodecyl sulfate (SDS) (4%) and analyzed using 15% SDSEEPAGE with 5% stacking gel as described in (39) .
Results
Repair of AFB 1 lesions in vivo
The HCR assay has been used previously to study repair of different lesions in cells with different repair status (35, 36) . Here we used pSP72 plasmids carrying a b-lactamase gene, which allowed transformed cells to grow in the presence of ampicillin. Prior to introduction into cells, plasmids were covalently modified with AFB 1 -epoxide so that either AFB 1 -N 7 -dG or AFB 1 -FAPY adducts were introduced. The survival of the cells transformed with modified plasmids on ampicillincontaining media is possible only when complete or at least Repair of aflatoxin B 1 adducts in vivo partial repair of lesions has decreased the adduct burden ( Figure 3 ). Cells deficient in one or more of the repair pathways essential for removal of aflatoxin lesions should be more sensitive to the presence of the adducts. Thus, comparison of the survival of cell strains of different repair backgrounds on selective media allows one to establish which pathway or pathways are essential for repair AFB 1 -N 7 -dG or AFB 1 -FAPY adducts of in vivo. Figure 3 shows the survival of the E.coli cells transformed with the plasmids containing AFB 1 -N 7 -dG adducts on ampicillin-containing plates. The survival of the NERdeficient cells (both single uvrA and double uvrA/fpg mutants) was significantly less than that of the wild-type and the fpg mutant cells. For example, uvrA and uvrA/fpg cells transformed with a plasmid containing~25 adducts/plasmid were essentially non-viable, whereas 450% of the wild-type cells and fpg cells transformed with the same plasmid were able to survive. This result was predictable, as it has been shown that bulky adducts including the AFB 1 lesions are efficiently removed by NER enzymes in vitro and in vivo (27EE32). There is no evidence that the Fpg protein participates in repair of bulky adducts with an intact purine imidazole ring, such as found in AFB 1 -N 7 -dG adducts; thus, it is not surprising that the survival of the wild-type and the fpg cells are essentially the same. The decrease of survival observed for the double mutant cells (uvrA/fpg) compared with that of the wild-type is caused by the deficiency of NER and not by the absence of the Fpg protein, as a similar survival is observed for cells carrying the single uvrA mutant allele ( Figure 3A) .
It has been shown that the Fpg protein is capable of incising the AFB 1 -FAPY adducts in vitro (34), so we performed the HCR assay to determine if this protein contributes to the repair of these lesions in vivo. If true, one would expect to see the decreased survival in fpg mutant cells transformed with the plasmids enriched for this type of lesion compared with survival of wild-type cells, as well as a decrease of survival of the double uvrA/fpg mutant compared with that of the single uvrA mutant cells. The results presented in Figure 3B suggest, however, that this is not the case. The results show that both the wild-type and the fpg mutant are similarly resistant to the presence of the AFB 1 -FAPY adduct-containing plasmids used for the transformation. For example, 412% survival was observed when the wild-type and fpg cells were transformed with plasmids containing at average 18 adducts, compared with the uvrA mutant and the double uvrA/fpg mutant cells, which could not tolerate 410 adducts/plasmid. The similarity of the survival curves obtained for the latter two cell lines also suggests that the contribution of the Fpg protein to the repair of AFB 1 -FAPY adducts in vivo is negligible.
Our results suggest that AFB 1 -N 7 -dG and AFB 1 -FAPY adducts, both of which are bulky lesions, are good substrates for E.coli NER proteins, which are able to remove the lesions even at the basal level of NER expression without SOS induction. It is also noteworthy that, overall, all cell lines tolerated the AFB 1 -N 7 -dG lesion better than the AFB 1 -FAPY lesions (compare Figure 3A and B) . This finding can be correlated with higher DNA replication blocking caused by AFB 1 -FAPY adduct observed in a different system (14) .
Interactions of MutM and hOGG1 proteins with DNA containing 8-oxoG, Me-FAPY or AFB 1 -FAPY lesions in vitro
Fpg is a DNA glycosylase with a broad substrate-specificity, and is capable of incising a variety of DNA lesions, most of which are derived from oxidative damage (33) . Fpg is also reported to remove AFB 1 -FAPY adducts in vitro (34) . To compare the substrate specificity of Fpg protein for different types of DNA damage, we used an in vitro assay in which the double-stranded DNA substrates with a 32 P-labeled strand containing the damage are allowed to interact with purified Fpg or its human analog, hOGG1 ( Figure 4A ). Under the test conditions, efficient cleavage was observed in the cases of 8-oxoG and Me-FAPY lesions, verifying the activity of the enzymes on known substrates. Consistent with previous data (37) d-elimination products observed in the case of the Fpg protein migrated faster than b-elimination products generated by hOGG1 protein, which lacks homology with the Fpg protein and has a different AP lyase mechanism. No cleavage, however, was observed in the case of the AFB 1 -FAPY lesion under the same experimental conditions ( Figure 4A ).
The assay shown in Figure 4A measures the DNA nicking efficiency due to the associated lyase activity that follows the glycosidic cleavage event. As a caveat to the experiment described above ( Figure 4A ), it is possible that Fpg or hOGG1 displayed some glycosylase activity against the AFB 1 -FAPY lesion, but the protein may not have displayed detectable lyase activity, leading to a strand break. This would parallel the observation made by Hazra and coworkers that the lyase activity of hOGG1 against the 8-oxoG is weak (44) . We addressed this possibility by utilizing NaBH 4 , which reduces the Schiff base intermediates, thus producing a stable covalent cross-link between Fpg or hOGG1 and abasic sites. Covalent enzymeEEDNA complexes were detected only when the substrates contained 8-oxoG and Me-FAPY lesions, but not with the AFB 1 -FAPY ( Figure 4B ) nor with the unmodified guanine (data not shown). Identical results were obtained when Fpg from Trevigen was used in the same experiments (data not shown). These findings indicated that AFB 1 -FAPY lesion is at best a poor substrate for both proteins, compared with canonical substrates for bacterial Fpg and human hOGG1 proteins.
Discussion
The primary cationic AFB 1 -N 7 -dG adduct, formed when metabolically activated AFB 1 is allowed to react with DNA, can either undergo a base-catalyzed conversion into imidazole ringopened AFB 1 -FAPY adducts or depurinate forming abasic sites (4,13). All three lesions are thought to contribute to mutations (mostly G to T transversions) observed upon AFB 1 treatment of cells (14, 15) . The deoxyglycosidic bond of AFB 1 -FAPY adduct is much more stable than that of the cationic AFB 1 -N 7 -dG adduct (13) and, most importantly, the FAPY adduct persists in mammalian cells (24) . In contrast, the AFB 1 -N 7 -dG adducts are efficiently removed in mammals, although both lesions are repaired efficiently in bacteria (25) . It has been shown that the NER system can repair both lesions in different organisms (29, 32) . According to NMR studies, the structures of both lesions in double-stranded DNA are similar, even though AFB 1 -FAPY adducts stabilize the DNA helix much more than the cationic AFB 1 -N 7 -dG adduct; this enhanced stabilization of the duplex by AFB 1 -FAPY could be a factor in its ability to evade repair (16, 18, 19, 22) . However, it has been shown that the bacterial uvrABC endonuclease, which bears a significant extent of homology with the mammalian NER system, binds and cleaves both lesions with equal efficiency in vitro (32) .
One possible explanation for the more efficient repair of AFB 1 -FAPY lesions in bacteria versus mammals is the observation that the bacterial Fpg glycosylase (MutM) is able to incise AFB 1 -FAPY lesions in vitro (34) . It was reasonable to extrapolate that Fpg would contribute to the repair of AFB 1 -FAPY lesions in bacteria, but not in mammals, where proteins serving similar functions lack the homology with Fpg protein (reviewed in refs 45,46). Our results obtained by the HCR assay, however, suggest that it is not the case. When isogenic E.coli cells with different repair backgrounds were transformed with plasmids bearing an ampicillin resistance gene and containing either AFB 1 -N 7 -dG or AFB 1 -FAPY adducts, the observed survival trends on selective ampicillin media were the same for both adducts. Wild-type cells and fpg mutants were relatively resistant to the presence of both lesions, compared with the uvrA and the uvrA/fpg mutants ( Figure 3 ). This suggests that in E.coli both adducts are repaired preferentially by NER and the contribution of the Fpg protein, if any, is negligible.
Fpg protein has a broad substrate-specificity, including 8-oxoG and imidazole ring-opened purines (33) . A recently published analysis of the crystal structure of the E.coli Fpg protein bound to oxidatively damaged DNA (47) revealed that there is a compact negatively charged hydrophobic pocket formed in the active site of the protein into which the damaged DNA base is everted prior to the cleavage event (see figure 3 in ref. 47 ). Positioning of a bulky AFB 1 moiety into close proximity of this pocket would possibly cause significant distortion of the structure and presumably preclude recognition and/or flipping and/or cleavage of the AFB 1 -FAPY base, despite the existence of the same structural features as the FAPY and Me-FAPY due to the open imidazole ring of the modified dG. In the case of eukaryotic hOGG1 protein (48) , which lacks sequence homology with the E.coli Fpg protein, the compact damage-specificity pocket is also present and it is unlikely that the bulky AFB 1 -FAPY adduct can be efficiently ejected from the helix and excised by the hOGG1 protein.
Other than the prokaryotic proteins, the hOGG1 protein was shown to recognize the 8-oxoG damage through interactions with N 7 atom, rather than C 8 carbonyl function (48) , and it seems possible that this important interaction would be disrupted in the case of the presence of a bulky aflatoxin moiety on the N 7 atom. In addition, as the AFB 1 -FAPY was shown to stabilize the DNA double-helix presumably due to stacking interactions (19, 22) , significantly more energy would be required to flip the damaged base out of the helix. Overall, the structural data on the DNA glycosylases, whether prokaryotic or eukaryotic, suggest that the bulky adducts should be poor substrates for those proteins, consistent with our results obtained in vivo. Based on the fact that AFB 1 -FAPY adducts persist in mammals, one can speculate that these lesions are not removed efficiently by newly discovered enzymes from the NEIL family, even though it has been shown that at least one protein from this family (NEIL1) efficiently excises ring-open purines (reviewed in ref. 49 ). 
Repair of aflatoxin B 1 adducts in vivo
Also consistent with that view, our in vitro analysis of the interaction of purified Fpg and hOGG1 proteins with double-stranded DNA containing 8-oxoG, Me-FAPY or AFB 1 -FAPY suggests that the latter lesion is a poor substrate for both enzymes. No cleavage was observed when the DNA contained AFB 1 -FAPY lesion, whereas the 8-oxoG and Me-FAPY promoted efficient cleavage by both glycosylases (Figure 4) . Furthermore, reduction of the Schiff base reaction intermediates revealed covalent enzymeEEDNA complexes only for the 8-oxoG and Me-FAPY reactions, suggesting that the AFB 1 -FAPY base was not excised by either enzyme.
In contrast to our work, Chetsanga and Frenette (34) reported in their early study that radioactively labeled AFB 1 -FAPY is cleaved by purified Fpg protein in vitro. Another group (32) also observed nicking of the DNA containing AFB 1 -FAPY adducts by purified Fpg protein using an in vitro analysis similar to that used in our study. However, others (50) reported only very inefficient cleavage of AFB 1 -FAPY adducts by the Fpg protein. No comparison of the cleavage efficiency of the AFB 1 -FAPY adducts with other substrates have been made in any of these studies. Previously, it has been shown that the cleavage efficiency of another bulky lesion, the ring-opened C 8 -guanine-aminofluorene adduct, by the Fpg protein in vitro is 430-fold less than that of the 8-oxoG lesion (33), a difference that might also account for our results. In experiments by Chetsanga (34) and Oleykowski (32) where the cleavage of the AFB 1 -FAPY adducts by the Fpg protein was observed, significantly longer DNA substrates (calf thymus DNA and 115 bp double-stranded DNA, respectively) were used, so our 20mer substrates may not have been optimal for Fpg and hOGG1 cleavage. However, the fact that under exactly the same conditions, efficient cleavage was observed for 8-oxoG and Me-FAPY, still suggests that AFB 1 -FAPY is comparatively a poor substrate for those DNA glycosylases.
It is possible that the different rotamers of AFB 1 -FAPY adducts (discussed in ref. 14) are recognized differentially by the Fpg protein. In early studies of Fpg protein substrate specificity (33) , which were later confirmed by crystallographic analysis of the Fpg protein structure from Thermus thermophilus (51), it was shown that the C 8 and C 6 keto groups of the damaged purine bases are important for recognition by the enzyme. Other imidazole ring-opened species, FAPY and Me-FAPY, which are substrates for the Fpg protein also form similar rotameric structures (52, 53) . It has been proposed but not proven (33) that the rotamer that resembles the conformation of 8-oxoG (anti) is preferentially cleaved by the enzyme. The structure of the AFB 1 -FAPY in double-stranded DNA that has been determined so far by NMR (19) presumably corresponds to the major rotamer, while the structure of the minor rotamer is unknown. A comparison of this structure with the crystal structure of 8-oxoG (54) suggests that the positions of the C 8 carbonyl groups in those two cases are different. In the case of AFB 1 -FAPY, a hydrogen bond was predicted between the C 8 carbonyl group and N 6 H a atom of the 3 H -adjacent adenine, so it is not clear what would be the position of this functional group in other sequence contexts. Theoretically, it is possible that the minor rotamer positions the C 8 carbonyl group in a more favorable position for the Fpg protein and, consequently, may be a better substrate for it. According to Giri and Stone (22) , an NMR structure of the minor rotamer is currently under investigation, which may clarify this issue. However, even if the minor rotamer is a better substrate for the Fpg protein, it seems unlikely that it would be meaningful in vivo as this rotamer is unstable and easily converts into the major form at room temperature (14, 22) .
In summary, we observed that the AFB 1 -FAPY lesions are preferentially repaired by NER and not BER in vivo. Thus, the difference in repair of the AFB 1 -FAPY lesions in bacteria versus mammals must be explained by reasons other than differential contribution of the Fpg versus hOGG1 proteins. As it has been proposed earlier (32) , possible explanations for this are differential repair of those adducts by mammalian and bacterial NER, or differences in repair and accumulation in different parts of mammalian genome. As with many other DNA synthesis-blocking lesions (55) , lesions induced by AFB 1 were shown to be recombinagenic (56, 57) , and it remains to be determined if differential recombination could account for the observed differences between mammals and bacteria.
